Avantax Advisory Services Inc. lifted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,486 shares of the financial services provider’s stock after purchasing an additional 308 shares during the period. Avantax Advisory Services Inc.’s holdings in CME Group were worth $4,293,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Truvestments Capital LLC purchased a new stake in CME Group during the 3rd quarter worth approximately $26,000. SJS Investment Consulting Inc. increased its stake in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares in the last quarter. Dunhill Financial LLC increased its stake in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares in the last quarter. Financial Life Planners purchased a new stake in CME Group during the 4th quarter worth approximately $32,000. Finally, Knuff & Co LLC purchased a new stake in CME Group during the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a report on Monday, March 10th. Morgan Stanley increased their price target on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a report on Wednesday, February 19th. Royal Bank of Canada increased their price target on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Finally, Citigroup cut CME Group from a “buy” rating to a “neutral” rating and cut their price target for the company from $255.00 to $250.00 in a report on Monday, January 6th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $238.93.
CME Group Trading Down 0.4 %
Shares of CME Group stock opened at $258.68 on Friday. The firm has a market capitalization of $93.22 billion, a price-to-earnings ratio of 26.75, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $263.65. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a 50 day moving average of $242.80 and a 200 day moving average of $232.32.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.93%. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
CME Group announced that its Board of Directors has initiated a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
Insider Transactions at CME Group
In other news, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,076 shares of company stock worth $4,271,496 over the last ninety days. Company insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to invest in marijuana stocks in 7 steps
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.